Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Quanterix (QTRX) EPS (Weighted Average and Diluted) (2019 - 2026)

Quanterix posted quarterly EPS (Weighted Average and Diluted) of -$0.37 for Q1 2026, up 30.19% year-on-year from -$0.28 in Q1 2025, and up 21.28% on a QoQ basis from -$0.47 in Q4 2025.

Quanterix (QTRX) has 8 years of EPS (Weighted Average and Diluted) data on file, last reported at -$0.37 in Q1 2026.

  • For the quarter ending Q1 2026, EPS (Weighted Average and Diluted) rose 30.19% year-over-year to -$0.37; the trailing twelve-month figure through Mar 2026 stood at -$2.34 (down 88.71% YoY), and the FY2025 full-year result was -$2.51, down 151.0% from the prior year.
  • EPS (Weighted Average and Diluted) for Q1 2026 stood at -$0.37, up from -$0.47 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at -$0.15 in Q2 2023 and bottomed at -$0.99 in Q3 2022.
  • The 5-year median for EPS (Weighted Average and Diluted) is -$0.37 (2026), against an average of -$0.43.
  • The widest annual swing landed in 2023, when EPS (Weighted Average and Diluted) jumped 81.82%; it then slumped 305.26% in 2025.
  • A 5-year view of EPS (Weighted Average and Diluted) shows it stood at -$0.49 in 2022, then jumped by 53.06% to -$0.23 in 2023, then sank by 30.43% to -$0.3 in 2024, then tumbled by 56.67% to -$0.47 in 2025, then rose by 21.28% to -$0.37 in 2026.
  • The last three EPS (Weighted Average and Diluted) figures came in at -$0.37 (Q1 2026), -$0.47 (Q4 2025), and -$0.73 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Weighted Avg. Diluted) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 0.61
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 1.93
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 0.89
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 0.90
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 0.66
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 0.51
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 0.85
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 2.24
10 Quanterix 165.84 Mn 66.57 Mn 15.57 Mn -0.37

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -0.37
Dec 31, 2025 -0.47
Sep 30, 2025 -0.73
Jun 30, 2025 -0.77
Mar 31, 2025 -0.53
Dec 31, 2024 -0.30
Sep 30, 2024 -0.22
Jun 30, 2024 -0.19
Mar 31, 2024 -0.29
Dec 31, 2023 -0.23
Sep 30, 2023 -0.18
Jun 30, 2023 -0.15
Mar 31, 2023 -0.19
Dec 31, 2022 -0.49
Sep 30, 2022 -0.99
Jun 30, 2022 -0.73
Mar 31, 2022 -0.49
Dec 31, 2021 -0.49
Sep 30, 2021 -0.43
Jun 30, 2021 -0.33
Mar 31, 2021 -0.29
Dec 31, 2020 -0.32
Sep 30, 2020 0.07
Dec 31, 2019 -0.39
Sep 30, 2019 -0.37